Real-World Efficacy of Weekly Somatrogon on Growth and Bone Health in Pediatric Growth Hormone Deficiency: A 12-Month Retrospective Cohort Study

Puntos clave

• Weekly somatrogon treatment significantly improves growth outcomes in children with growth hormone deficiency, enhancing their overall health.
• The study tracks growth and bone health metrics over 12 months in pediatric patients, highlighting substantial benefits from somatrogon.
• This retrospective cohort study analyzed data from multiple clinics, establishing a real-world context for the treatment's effectiveness.
• The findings suggest somatrogon could become a key option for managing pediatric growth hormone deficiency, warranting further research.